Search results for "Peg"

showing 10 items of 460 documents

Boron functionalization of BODIPY by various alcohols and phenols.

2013

The synthesis of new B–O BODIPY derivatives functionalized with different alkoxy or diarylalkoxy derivatives is described. These compounds were synthesized from the reaction of different B–F BODIPY precursors with various alcohols and phenols, in the presence of AlCl3. Water-soluble dyes could be synthesized as well with this method, specifically by the introduction of polyethyleneglycol (PEG) groups. A photophysical study of the different compounds was performed, and showed that the B–O BODIPY derivatives exhibit rich fluorescence properties. Finally, the conjugation of the BODIPY core has been extended using two distyryl groups, hence providing NIR emitting BODIPY derivatives, in which on…

Organic Chemistrychemistry.chemical_elementBiochemistryFluorescencechemistry.chemical_compoundchemistryPEG ratioAlkoxy groupOrganic chemistrySurface modificationPhenolsPhysical and Theoretical ChemistryBODIPYBoronOrganicbiomolecular chemistry
researchProduct

STRATEGIE DI DIREZIONAMENTO ALL’EPATOCARCINOMA DI FARMACI ANTITUMORALI MEDIANTE SISTEMI NANOPARTICELLARI E DI VISUALIZZAZIONE IN CELLULE TUMORALI DEL…

Lo scopo di questo lavoro di tesi è stato quello di realizzare nuovi sistemi nanoparticellari per il direzionamento di farmaci o di agenti per l’imaging, potenzialmente utilizzabili per la terapia e/o per la diagnosi dell’epatocarcinoma (HCC), in particolare per quelle forme caratterizzate dall’overespressione del recettore di membrana degli epatociti ASGP-R o del recettore mitocondriale TSPO. In particolare, nel capitolo 2 sono state descritte la sintesi, la caratterizzazione chimico fisica, la capacità di internalizzazione cellulare e l’efficacia antitumorale di un nuovo sistema nanoparticellare, costituito da un dendrimero a struttura poli-amido-aminica (PAMAM) di quarta generazione, opp…

PAMAM dendrimerLactobionic acidQD nanoparticleTSPO receptorSPIONimagingSorafenibASGPR receptor; TSPO receptor; HEPATOCELLULAR CARCINOMA; Lactobionic acid; Sorafenib; PAMAM dendrimer; QD nanoparticles; Micelles pegilated; SPION; magnetic targeting;imaging;magnetic targetingASGPR receptorMicelles pegilatedSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoHEPATOCELLULAR CARCINOMA
researchProduct

Anisakis pegrefii and Anisakis simplex sensu strictu in Mediterranean sea

2014

BACKGROUND: Anisakiasis is a parasitic zoonosis caused by ingestion of nematode larvae belonging to Anisakidae family, following consumption of raw, undercooked or improperly processed fish. Mediterranean sea represent an aquatic ecosystem particularly suitable for the development of Anisakid larvae. The aim of this work is to found intra-species and inter-species nucleotide differences by phylogenetic analysis in this geographical area. METHODS: In the period from January to November 2013, 584 fish from Mediterranean sea were screened, and they were found parasitised of 6318 type I anisakid larvae. Fish were eviscerated and observed by stereo microscope to collect larvae relived in the vis…

PCRAnisakis pegrefiiMediterranean seaAnisakis simplex
researchProduct

Solubilisation of multi walled carbon nanotubes by alpha-pyrene functionalised PMMA and their liquid crystalline self-organisation.

2008

alpha-Pyrene functionalised poly(methyl methacrylate) (PMMA) chains were synthesised by RAFT polymerisation and found to be highly efficient to solubilise and disentangle multi walled carbon nanotubes that can now self-organise as liquid crystalline phases in PMMA and PEG 400 matrices.

PEG 400Materials scienceLiquid crystallineMetals and AlloysGeneral ChemistryRaftCarbon nanotubeCatalysisSurfaces Coatings and FilmsElectronic Optical and Magnetic Materialslaw.inventionchemistry.chemical_compoundSelf organisationchemistryPolymerizationChemical engineeringlawMaterials ChemistryCeramics and CompositesOrganic chemistryPyreneMethyl methacrylateChemical communications (Cambridge, England)
researchProduct

Rheological characterization of chitosan matrices: Influence of biopolymer concentration

2007

Viscoelastic properties of chitosan (CH), chitosan-poly(ethylene glycol) 400 (CH-PEG), and chitosan-poly(ethylene glycol) 400 with glyoxal as crosslinking agent (CH-PEG-Gly) systems were studied to analyze the effect of chitosan concentration (from 0.83 to 1.67%). Dynamic moduli increase as chitosan concentration increases for all systems. For CH and CH-PEG systems the loss modulus (G″) is greater than the storage modulus (G′) with predominance of the viscous over the elastic behavior. This corresponds to the characteristic behavior of solutions (nonstructured systems). The presence of PEG 400 induces a complementary reinforcement of the mechanical properties of the system. Except for the l…

PEG 400Materials sciencePolymers and PlasticsRheometrytechnology industry and agricultureConcentration effectmacromolecular substancesGeneral ChemistryDynamic mechanical analysisViscoelasticitySurfaces Coatings and Filmschemistry.chemical_compoundChemical engineeringchemistryDynamic modulusMaterials ChemistryGlyoxalComposite materialEthylene glycolJournal of Applied Polymer Science
researchProduct

Green Extraction of Polyphenols from Waste Bentonite to Produce Functional Antioxidant Excipients for Cosmetic and Pharmaceutical Purposes: A Waste-t…

2022

In an ever-growing perspective of circular economy, the development of conscious, sustainable and environmental-friendly strategies to recycle the waste products is the key point. The scope of this work was to validate the waste bentonite from the grape processing industries as a precious matrix to extract polyphenols by applying a waste-to-market approach aimed at producing novel functional excipients. The waste bentonite was recovered after the fining process and opportunely pre-treated. Subsequently, both the freeze dried and the so-called “wet” bentonites were subjected to maceration. PEG200 and Propylene Glycol were selected as solvents due to their ability to dissolve poly…

PEG200PhysiologybentoniteClinical BiochemistryCell Biologywaste productBiochemistrycosmeceutical excipientsbentonite; waste product; extraction; polyphenols; grape processing industry; propylene glycol; PEG200; cosmeceutical excipients; pharmaceutical excipients; waste-to-market approachSettore CHIM/09 - Farmaceutico Tecnologico Applicativopropylene glycolwaste-to-market approachextractionpharmaceutical excipientsMolecular Biologygrape processing industrypolyphenolsAntioxidants
researchProduct

Intravitreal pegaptanib sodium for refractory pseudophakic macular oedema.

2008

Evaluate the efficacy of intravitreal pegaptanib sodium (Macugen®) in refractory pseudophakic cystoid macular oedema (CME). Prospective, nonrandomized, interventional case series. Four eyes of four patients with refractory pseudophakic CME to pars plana vitrectomy and intravitreal bevacizumab and triamcinolone, were treated with pegaptanib sodium, with a mean follow up of 4 months. Pre- and postinfection examinations included assessment of best-corrected visual acuity (BCVA) using the Early Treatment Diabetic Retinopathy Study chart (ETDRS), fluorescein angiography (FA), and optical coherence tomography (OCT). Visual acuity increased in all patients after intravitreal pegaptanib sodium. OCT…

Pars planaMalemedicine.medical_specialtyVisual acuityTriamcinolone acetonidegenetic structuresPseudophakiamedicine.medical_treatmentPegaptanibIntraocular lensVitrectomyAngiogenesis InhibitorsMacular EdemaVitrectomymedicinePegaptanib SodiumHumansProspective StudiesFluorescein AngiographyAgedDiabetic Retinopathymedicine.diagnostic_testbusiness.industryAptamers NucleotideMiddle AgedFluorescein angiographyeye diseasesSurgeryOphthalmologymedicine.anatomical_structureTreatment OutcomeFemalesense organsmedicine.symptombusinessTomography Optical Coherencemedicine.drugEye (London, England)
researchProduct

Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients with HCV genotype 3

2010

Background & Aims: The benefit of individualizing treatment for patients with genotype 3 HCV infection on the basis of viral clearance at week 4 (wk4-R) has not been firmly established. Methods: Four hundred and fourteen patients received Peginterferon alpha-2b plus 1000–1200 mg of ribavirin daily according with body weight > or <75 kg. Patients were randomized to standard 24 weeks (Std24) or to a 12 or 36 weeks variable treatment duration (Var12/36). In the variable treatment arm, patients with or without wk4-R were allocated to either 12 or 36 weeks duration. Results: At treatment week 4, HCV RNA was undetectable in 262 patients (63.3%), 136 in the Std24, and 126 in the Var12/36 group (p …

Peg-interferonRibavirinHCV genotype 3Short treatment
researchProduct

Exploring the diversity of the human blood virome

2021

This article belongs to the Special Issue Virus Bioinformatics 2022.

PegivirusDiseaseGenome ViralMicrobiologyGenomeVirusArticleVirologyPegivirusHumansHuman viromeVirus discoveryMassive parallel sequencingbiologyBlood viromeViromebiology.organism_classificationAnellovirusQR1-502Healthy VolunteersOrphan virusInfectious DiseasesEvolutionary biologyMetagenomicsSpainVirusesMetagenomicsOrphan virusorphan virus; blood virome; anellovirus; pegivirus; virus discovery; metagenomics
researchProduct

Margination of Fluorescent Polylactic Acid-Polyaspartamide based Nanoparticles in Microcapillaries In Vitro: the Effect of Hematocrit and Pressure.

2017

The last decade has seen the emergence of vascular-targeted drug delivery systems as a promising approach for the treatment of many diseases, such as cardiovascular diseases and cancer. In this field, one of the major challenges is carrier margination propensity (i.e., particle migration from blood flow to vessel walls); indeed, binding of these particles to targeted cells and tissues is only possible if there is direct carrier–wall interaction. Here, a microfluidic system mimicking the hydrodynamic conditions of human microcirculation in vitro is used to investigate the effect of red blood cells (RBCs) on a carrier margination in relation to RBC concentration (hematocrit) and pressure drop…

Pharmaceutical ScienceNanoparticle02 engineering and technologyPolymeric nanoparticleHematocrit01 natural sciencesAnalytical Chemistrychemistry.chemical_compoundDrug Delivery SystemsPolylactic acidDrug Discoveryαβ-poly-(N-2-hydroxyethyl)-dl-aspartamide (PHEA)medicine.diagnostic_testMolecular StructureChemistry">l-aspartamide (PHEA)poly(ethylene glycol) (PEG)Microfluidic Analytical Techniques021001 nanoscience & nanotechnologypolymeric nanoparticlesBiochemistryHematocritmarginationChemistry (miscellaneous)Drug deliveryMolecular Medicine0210 nano-technologyDrug carrier">PolyestersIn Vitro Techniquesα β-poly-(N-2-hydroxyethyl)-D010402 general chemistryFluorescenceArticleMicrocirculationαβ-poly-(N-2-hydroxyethyl)-<span style="font-variant: small-caps;">d</span><span style="font-variant: small-caps;"></span><span style="font-variant: small-caps;">l</span>-aspartamide (PHEA); poly(lactic acid) (PLA); poly(ethylene glycol) (PEG); polymeric nanoparticles; marginationlcsh:QD241-441Rhodaminelcsh:Organic chemistrypoly(lactic acid) (PLA)PEG ratiomedicineHumansPhysical and Theoretical ChemistryParticle Sizeα β-poly-(N-2-hydroxyethyl)-DL-aspartamide (PHEA)αβ-poly-(N-2-hydroxyethyl)-RhodaminesMicrocirculationOrganic Chemistry0104 chemical sciencesBiophysicsNanoparticles">dPeptidesMolecules (Basel, Switzerland)
researchProduct